Total Funding
69
59
Total FundingSeries A raised
Growth Score
-10 pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
101243
FIMECS is a drug discovery company that develops protein degradation therapeutics for cancers and difficult-to-treat diseases.
- Yusuke Tominari: Representative Director, CEO, CSO, and Founder
About the Company
FIMECS is a protein degradation technology-based drug discovery biotech focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The human body is comprised of at least 18,097 proteins.It has been revealed that 1,500 of them are related to certain diseases, nevertheless only about 300
proteins have been regarded as druggable targets by small molecule drug discovery and all the rest have been undruggable.
